Machine learning in Alzheimer’s disease
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
Are we making progress in dementia treatment?
Atypical parkinsonian disorders
Kailash P. Bhatia
The promise and perils of cognitive training in dementia